Category: News

10. May 2014 – Alacris at Lange Nacht der Wissenschaften LNDW

At the site of the future Gründer- und Technologiezentrum on every hour Alacris Theranostics and Erdmann Technologies will inform about personalised medicine and cancer or offer a tour on the grounds of the former U.S. Hospitals and future founder and technology center. The Regionalmanagement Berlin Südwest and profound, the start-up support of the Freie Universität […]

Read More

Alacris Theranostics: ModCellTM system will use the SAP HANA® platform

Berlin, 1st April 2014 – Alacris Theranostics has entered into a project with SAP AG (NYSE: SAP) to use the SAP HANA® platform to enable Alacris’ proprietary ModCell™ system. Using SAP HANA is expected to accelerate the modelling and prediction of drug action by Alacris’ ModCellTM system by a factor of several thousand. This allows […]

Read More

Alacris Theranostics: Virtual Patient Platform

Alacris Theranostics and the SAP Innovation Center are working closely together on new IT solutions for a virtual patient platform. The project is addressing the significant IT challenges associated with the computer simulations of virtual patients. Watch the video here:

Read More

Alacris Theranostics: Partner of major study to uncover genetic key to treating bone diseases

Alacris Theranostics became a member of an international research project to analyse the genetic and molecular causes of bone diseases, including arthritis and osteoporosis, and to pinpoint possible future treatments. The European Commission has awarded over £10,000,000 (€12m) to SYBIL, a five year project involving 18 partners across Europe, which hopes to make breakthroughs in […]

Read More

Alacris Theranostics: Announces Illumina CSPro Certification

Alacris Theranostics GmbH announced today that it has successfully completed Illumina CSPro™ certification for next generation sequencing (NGS); gaining entry to an elite global group of Illumina genomics service providers. Illumina Inc., a San Diego-based company, provides leading-edge genetic analysis tools to genomics centers worldwide. Illumina CSPro is the collaborative service provider partnership dedicated to […]

Read More

Alacris Theranostics: Flagship Project for Berlin

As part of the series “Köpfe und Karrieren” (Heads and Careers) Berlin Regional Management Southwest (rmsw) portraits Alacris Theranostics GmbH and its CEO Dr Bodo Lange. The objectives of the rmsw are particularly the further development of the project “Technology Center Southwest” and the promotion of networks with stakeholders from industry, science, culture, politics and […]

Read More

Alacris Theranostics: Tomorrow Today with Alacris Theranostics

Dr. Alexander Kühn, Head of Modeling, Alacris Theranostics GmbH, was invited for a studio discussion for the science magazine Tomorrow Today of Deutsche Welle. Here he talked about whether information technology can help make the world healthier, and what role is played by the virtual patient. Watch the video here:

Read More

Alacris Theranostics enters agreement with GSK to use ModCellTM System for early stage cancer research

Berlin, 14th November 2012 – Alacris Theranostics has entered into an agreement with GlaxoSmithKline (GSK) to apply Alacris’ proprietary ModCell™ System, developed at the Max Planck Institute for Molecular Genetics and licensed exclusively to Alacris, for drug stratification using data from early stage cancer drug discovery at GSK. GSK will provide to Alacris pre-clinical biology […]

Read More

QIAGEN to acquire stake in Alacris

QIAGEN has signed an agreement for the acquisition of  a strategic stake in Alacris Theranostics GmbH, a German start-up company using the novel technology ModCellTM to develop individualized cancer treatment strategies based upon a patient’s genomic profile, and for the acquisition of an exclusive option to access all biomarkers emerging from this discovery program.  The […]

Read More